Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Berry Genomics Co.,Ltd
  6. Summary
    000710   CNE000000PN7

BERRY GENOMICS CO.,LTD

(000710)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/20/2022 01/21/2022 01/24/2022 01/25/2022 01/26/2022 Date
19.01 18.51 17.6 16.29 16.43 Last
8262886 6926700 7470033 10234050 4429680 Volume
-3.01% -2.63% -4.92% -7.44% +0.86% Change
Estimated financial data (e)
Sales 2021 1 833 M 288 M 288 M
Net income 2021 102 M 16,0 M 16,0 M
Net Debt 2021 - - -
P/E ratio 2021 56,7x
Yield 2021 0,06%
Sales 2022 2 185 M 344 M 344 M
Net income 2022 162 M 25,5 M 25,5 M
Net Debt 2022 - - -
P/E ratio 2022 35,7x
Yield 2022 0,06%
Capitalization 5 762 M 912 M 906 M
Capi. / Sales 2021 3,14x
Capi. / Sales 2022 2,64x
Nbr of Employees 1 496
Free-Float 56,9%
More Financials
Company
Berry Genomics Co Ltd is a company mainly engaged in medical testing related services. The Company's business is comprised of basic scientific research services, medical testing services, testing reagent sales and testing equipment sales. The basic scientific research services business provides the clients with multiple sequencing platforms for testing projects, such as transcriptome sequencing, human whole exome... 
Sector
Healthcare Facilities & Services
Calendar
02/07 | 02:30am
More about the company
Ratings of Berry Genomics Co.,Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BERRY GENOMICS CO.,LTD
2021BERRY GENOMICS CO.,LTD(SZSE : 000710) dropped from Shenzhen Stock Exchange Component Index
CI
2021BERRY GENOMICS CO.,LTD(SZSE : 000710) dropped from Shenzhen Stock Exchange Component A Sha..
CI
2021Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30,..
CI
2021Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021ALIBABA HEALTH INFORMATION TECHNOLOG : Berry Genomics to Build Early Cancer Screening Syst..
MT
2021Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
2021Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 20..
CI
2021Berry Genomics Co.,Ltd cancelled the transaction announced on August 13, 2020
CI
2021Twist Bioscience Corporation and Berry Genomics to Offer New NGS Solution to Advance Re..
CI
2021Six shareholders agreed to acquire 6.17% stake in Fujian Herui Gene Technology Co., Ltd..
CI
2020Fuzhou Hanxing Jinghe Investment Co., Ltd. signed an equity transfer agreement to acqui..
CI
2020Berry Genomics Co.,Ltd's Equity Buyback announced on December 24, 2019, has expired.
CI
2020Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30,..
CI
2020Tranche Update on Berry Genomics Co.,Ltd's Equity Buyback Plan announced on December 24..
CI
2020Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2020
CI
More news
News in other languages on BERRY GENOMICS CO.,LTD
2021Alibaba Health et Berry Genomics vont créer un système de dépistage précoce du cancer
More news
Chart BERRY GENOMICS CO.,LTD
Duration : Period :
Berry Genomics Co.,Ltd Technical Analysis Chart | 000710 | CNE000000PN7 | MarketScreener
Technical analysis trends BERRY GENOMICS CO.,LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 16,43 CNY
Average target price 56,76 CNY
Spread / Average Target 245%
EPS Revisions
Managers and Directors
Dai Xing Zhou General Manager & Director
Dong Wang CFO, Board Secretary & Deputy General Manager
Yang Gao Chairman & Deputy General Manager
Quan Zhou Chairman-Supervisory Board
Zi Cai Liang Independent Director
Sector and Competitors